Cellestial Health Ltd
Cellestial Health is a preclinical pharmaceutical development company which spun out from the University of Cambridge. Our small molecule therapeutics stabilise networks of brain cells called astrocytes to slow down or stop the progression of Parkinson's - the fastest-growing neurological disorder globally. Further, there is a strong scope for expansion to other conditions of the brain.